CRISPR Epigenome Editing Reverses Prader-Willi Syndrome Defects
Researchers have successfully used CRISPR-based epigenome editing to reverse molecular defects in cellular models of Prader-Willi syndrome. The breakthrough demonstrates restoration of silenced genes and functional recovery in hypothalamic organoids, offering new therapeutic possibilities.
